BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28652021)

  • 1. Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells.
    Li H; Meng QH; Noh H; Batth IS; Somaiah N; Torres KE; Xia X; Wang R; Li S
    Cancer Lett; 2017 Sep; 403():216-223. PubMed ID: 28652021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.
    Brungs D; Lynch D; Luk AW; Minaei E; Ranson M; Aghmesheh M; Vine KL; Carolan M; Jaber M; de Souza P; Becker TM
    World J Gastroenterol; 2018 Feb; 24(7):810-818. PubMed ID: 29467551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis.
    Zhu P; Stanton ML; Castle EP; Joseph RW; Adams DL; Li S; Amstutz P; Tang CM; Ho TH
    J Transl Med; 2016 Jul; 14(1):198. PubMed ID: 27369977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma.
    Vismara M; Reduzzi C; Silvestri M; Murianni F; Lo Russo G; Fortunato O; Motta R; Lanzoni D; Giovinazzo F; Miodini P; Pasquali S; Suatoni P; Pastorino U; Roz L; Sozzi G; Cappelletti V; Bertolini G
    Clin Chem; 2022 May; 68(5):691-701. PubMed ID: 35304611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection and clinical significance of circulating tumor cells in osteosarcoma using immunofluorescence combined with in situ hybridization].
    Zhang HQ; Li MH; Wang Z; Lan PH; Lu YJ; Chen GJ; Wang L
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):485-489. PubMed ID: 28728292
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells.
    Sheng Y; Wang T; Li H; Zhang Z; Chen J; He C; Li Y; Lv Y; Zhang J; Xu C; Wang Z; Huang C; Wang L
    Oncotarget; 2017 Jan; 8(5):8801-8806. PubMed ID: 28187533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreservation of Circulating Tumor Cells for Enumeration and Characterization.
    Nejlund S; Smith J; Kraan J; Stender H; Van MN; Langkjer ST; Nielsen MT; Sölétormos G; Hillig T
    Biopreserv Biobank; 2016 Aug; 14(4):330-7. PubMed ID: 27092845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report.
    Qiao YY; Lin KX; Zhang Z; Zhang DJ; Shi CH; Xiong M; Qu XH; Zhao XH
    World J Gastroenterol; 2015 Jul; 21(25):7921-8. PubMed ID: 26167094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.
    Fizazi K; Morat L; Chauveinc L; Prapotnich D; De Crevoisier R; Escudier B; Cathelineau X; Rozet F; Vallancien G; Sabatier L; Soria JC
    Ann Oncol; 2007 Mar; 18(3):518-21. PubMed ID: 17322541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
    Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
    Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells in sarcomas: a brief review.
    Chang L; Asatrian G; Dry SM; James AW
    Med Oncol; 2015 Jan; 32(1):430. PubMed ID: 25491143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
    Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I
    Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomagnetic antibody plus aptamer pseudo-DNA nanocatenane followed by rolling circle amplication for highly-sensitive CTC detection.
    Wang J; Dong HY; Zhou Y; Han LY; Zhang T; Lin M; Wang C; Xu H; Wu ZS; Jia L
    Biosens Bioelectron; 2018 Dec; 122():239-246. PubMed ID: 30267982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal marker and detection tool for human sarcoma circulating tumor cells.
    Satelli A; Mitra A; Cutrera JJ; Devarie M; Xia X; Ingram DR; Dibra D; Somaiah N; Torres KE; Ravi V; Ludwig JA; Kleinerman ES; Li S
    Cancer Res; 2014 Mar; 74(6):1645-50. PubMed ID: 24448245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
    Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
    Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.